Stanford University
Showing 41-50 of 127 Results
-
Gentaro Ikeda
Instructor, Medicine - Cardiovascular Medicine
BioDr. Ikeda is a physician-scientist who develops innovative diagnostic and therapeutic modalities for patients with cardiovascular disease. Based on his clinical experience as a cardiologist, he has become aware of major clinical shortcomings, specifically in the current pharmaceutical therapies for myocardial infarction (MI) and chronic heart failure (HF). Some evidence-based drug therapies, including β-blockers, ivabradine, and renin-angiotensin-aldosterone antagonists are difficult to apply to critical patients due to adverse side effects. Drugs that have shown efficacy in basic animal experiments have failed to show significant benefits in clinical trials. To address these problems, he moved to academia to conduct translational research. During his graduate training in the Egashira Lab, he focused on drug delivery systems (DDS) that target mitochondria in animal models of MI. He obtained advanced skills in molecular biology, mitochondrial bioenergetics, and animal surgery. He realized the importance of translational research and the great potential of DDS to overcome many clinical problems. He developed nanoparticle-mediated DDS containing cyclosporine for the treatment of patients with MI. He published a first-author paper and received academic awards for his novel science. Since becoming a postdoctoral fellow in the Yang Lab, he has continued to build upon his previous training in translational research. He is currently developing an innovative therapy, namely, extracellular vesicles-mediated mitochondrial transfer for mitochondria-related diseases such as heart failure and mitochondrial disease.
-
Sneha Shah Jain MD, MBA
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Sneha S. Jain is a Clinical Assistant Professor of Medicine in the Division of Cardiovascular Medicine and Director of the GUIDE-AI Lab. She specializes in general cardiovascular medicine and preventive cardiology.
Dr. Jain pursued her undergraduate degree in Economics at Duke University and graduated with distinction. She received her medical degree from the Johns Hopkins School of Medicine and her MBA from Harvard Business School. She completed internal medicine residency training at Columbia/NewYork-Presbyterian, and fellowship training in cardiovascular medicine at Stanford University.
Her research focuses on the development and responsible evaluation of AI tools to augment healthcare delivery and improve patient outcomes. She works with the Data Science Team at Stanford Healthcare and the Stanford Center for Clinical Research to deploy and prospectively evaluate AI solutions across the healthcare enterprise. She serves on the American College of Cardiology Healthcare Innovation Section leadership council, the American Heart Association Expert Panel for the AI Validation Lab, and as an Expert AI consultant for the Journal of the American College of Cardiology. -
Roy Mattathu John, MD, PhD, FRCP
Clinical Professor, Medicine - Cardiovascular Medicine
BioDr. John is a fellowship-trained cardiologist with more than 25 years of experience. He is a clinical professor in the Department of Medicine at Stanford University School of Medicine.
He originally earned board certification in clinical cardiac electrophysiology in 1996 and has continued to recertify. He also has earned board certification in cardiovascular disease and internal medicine.
Dr. John diagnoses and manages all forms of cardiac arrhythmias including atrial fibrillation and ventricular arrhythmias. His special interests include catheter ablation for SVT, atrial arrhythmias, pacemaker and defibrillator implants, and lead extraction.
He has conducted extensive research. He has participated in large multi-center clinical trials, including over 30 studies as a primary investigator of drugs, devices, and ablation techniques. He helped pioneer a new way to manage scar-related ventricular tachycardia. He also helped develop innovations in cardiac pacemaker technology.
Dr. John has authored over 200 publications that include 126 original research papers. They have appeared in reputed journals such as the New England Journal of Medicine, Circulation, Lancet, Journal of the American College of Cardiology, European Heart Journal, Heart Rhythm, Journal of Cardiovascular Electrophysiology, and many more. Topics have included innovative, new techniques and technologies for the treatment of supraventricular arrhythmias, atrial fibrillation, ventricular tachycardia, catheter ablation, lead extraction, cardiac pacing, and defibrillation.
He was a member of the editorial board for Circulation and is currently on the editorial board of the publications Heart Rhythm Journal, Arrhythmia and Electrophysiology, Journal of Cardiac Electrophysiology, and Journal of Innovations in Cardiac Rhythm Management.
Dr. John also has written several chapters for medical textbooks such as Harrison’s Principles of Internal Medicine, Zipes Textbook on Cardiac Electrophysiology - Cell to Bedside, Conn’s Current Therapy, Electrical Disorders of the Heart, Cardiac Mapping, and many more.
He has made invited presentations to his peers at scientific sessions of the Heart Rhythm Society, American Heart Association, American College of Cardiology, and Heart Failure Society. He has delivered more than 60 national and international lectures. Subjects include cardiac pacing, defibrillation, heart failure, and arrhythmia management including catheter ablation for arrhythmias.
Dr. John is a fellow of the American College of Cardiology, Heart Rhythm Society, and Royal College of Physicians of London.
He has volunteered his time and expertise to provide free cardiac care to underserved patients in Bolivia, India, and Kenya. -
Neil M. Kalwani, MD, MPP
Clinical Instructor, Medicine - Cardiovascular Medicine
BioDr. Neil M. Kalwani is a board-certified, fellowship-trained cardiologist with Stanford Health Care. He is also a clinical instructor in the Department of Medicine, Division of Cardiovascular Medicine at Stanford University School of Medicine. In addition, he serves as director of preventive cardiology at the Veterans Affairs (VA) Palo Alto Health Care System.
Dr. Kalwani specializes in general and preventive cardiology care. He has expertise in treating high cholesterol and other risk factors to prevent and stop the progression of coronary artery disease and other forms of atherosclerosis. He provides compassionate care centered around his patients' goals and prioritizes effective therapies based on the latest evidence to improve heart health and overall well-being.
Dr. Kalwani’s research focuses on innovations in care delivery designed to improve the value of care for people living with cardiovascular disease. He is especially interested in telemedicine and its impact on cardiology care, including on quality of care, practice patterns, and access. He has also investigated clinical decision support for cardiac testing, measurement of patient-reported outcomes for heart disease, and lipoprotein (a) testing patterns.
Dr. Kalwani has published his research in many peer-reviewed journals, including Circulation, the American Heart Journal, the American Journal of Preventive Cardiology, and the Journal of Telemedicine and Telecare. He has also presented his research at the American College of Cardiology (ACC) and American Heart Association (AHA) Scientific Sessions. His presentations have covered topics ranging from telemedicine’s effect on care delivery to the impact of physician productivity assessment on medical center performance.
Dr. Kalwani is a member of the ACC, AHA, and American Society of Echocardiography (ASE). -
Guson Kang
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Kang is an interventional cardiologist who specializes in the treatment of structural heart disease. He has expertise in complex coronary interventions, transcatheter aortic and mitral valve replacements, transcatheter mitral valve repair, left atrial appendage occlusion, PFO/septal defect closure, alcohol septal ablation, and paravalvular leak closure.
A Bay Area native, he graduated from Stanford University and obtained his medical degree at Yale University. He came back to Stanford to train in internal medicine, cardiology, and interventional cardiology before completing an advanced structural interventions fellowship at Ford Hospital. -
Michael S. Kapiloff, MD, PhD
Reinhard Family Professor, Professor (Research) of Ophthalmology and, by courtesy, of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Michael S. Kapiloff is a faculty member in the Departments of Ophthalmology and Medicine (Cardiovascular Medicine) and a member of the Stanford Cardiovascular Institute. Although Dr. Kapiloff was at one time a Board-Certified General Pediatrician, he is currently involved in full-time basic science and translational research. His laboratory studies the basic molecular mechanisms underlying the response of the retinal ganglion cell and cardiac myocyte to disease. The longstanding interest of his laboratory is the role in intracellular signal transduction of multimolecular complexes organized by scaffold proteins. Recently, his lab has also been involved in the translation of these concepts into new therapies, including the development of new AAV gene therapy biologics for the prevention and treatment of heart failure and for neuroprotection in the eye.
URL to NCBI listing of all published works:
http://www.ncbi.nlm.nih.gov/sites/myncbi/michael.kapiloff.1/bibliography/40252285/public/?sort=date&direction=descending
For more information see Dr. Kapiloff's lab website: http://med.stanford.edu/kapilofflab.html -
Masataka Kawana
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Kawana joined the Advanced Heart Failure and Transplant Cardiology group in 2018. He completed his internal medicine, cardiovascular medicine, and heart failure training at Stanford. He also completed a postdoctoral research fellowship under Dr. James Spudich in the Department of Biochemistry. He is the Medical Director of Ambulatory Heart Failure and Cardiomyopathy Service in the Advanced Heart Failure program. He manages advanced heart failure patients in the clinic, CCU/heart failure service, and post-heart transplant/MCS service. His research interests are in the fundamental mechanism of inherited cardiomyopathies, and he studies the effect of gene mutation on the cardiac sarcomere function using cutting-edge biochemical and biophysical approaches, which would lead to the development of novel pharmacotherapy that directly modulates cardiac muscle protein. He is involved in multiple clinical trials for pharmacotherapy and novel device studies in heart failure and inherited cardiomyopathy.
-
Abha Khandelwal
Clinical Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsCardiovascular disease in Pregnancy
Valvular Heart Disease
Cardiomyopathy
Pericardial disease
Heart Disease in South Asians
Women's Cardiovascular Disease
